Product logins

Find logins to all Clarivate products below.


Interventional Oncology Devices | Medtech 360 | Market Analysis | US | 2019

The US market for interventional oncology devices continues to grow, driven by expanding treatable patient populations and increasing uptake of premium-priced technology. However, growth in this market will be hindered to some extent by mixed clinical data, which has somewhat deterred adoption of interventional oncology devices.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in the US across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Asia Pacific (Supplemental)
The Asia Pacific interventional oncology device market will see strong growth through 2033, driven by large and rapidly expanding patient population, increasing popularity of minimally invasive…
Report
Interventional Oncology Devices – Market Insights – Europe (Supplemental)
The European interventional oncology device market will see modest growth through 2033, driven by increasing incidence and prevalence rates of cancer, cost-effectiveness of ablation and…
Report
Interventional Oncology Devices – Market Insights – United States
The US market for interventional oncology devices will be driven by uptake of advanced and higher-priced technologies—such as radioembolization—favorable clinical data, expanding populations…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will grow modestly, driven by increasing complex CAD cases and the adoption of surgical technologies. Favorable clinical evidence, particularly in favor of CABG over PCI,…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market will see modest growth through 2033, driven by increasing incidence and prevalence rates of cancer, cost-effectiveness of ablation and…